<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00760487</url>
  </required_header>
  <id_info>
    <org_study_id>ALCONsurtor001.06</org_study_id>
    <nct_id>NCT00760487</nct_id>
  </id_info>
  <brief_title>Visual Function After Implantation of Bilateral AcrySof® Toric Natural Intraocular Lens</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect that placement and power of the AcrySof
      Toric has on post-operative visual acuity and spectacle independence for distance vision.
      This will be determined by comparing manifest refraction pre-operatively and post-operatively
      and by evaluating the rotational stability of the lens over time.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity (VA)</measure>
    <time_frame>Pre-operative, 1 month, 3 month, and 6 month post-operative</time_frame>
    <description>Pre-operative and 1 month, 3 month, and 6 month post-operative visual acuity (VA) measured in logMAR. LogMAR is the &quot;logarithm of the minimum angle of resolution&quot;. It is a unit of measure for visual acuity (VA).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spectacle Independence</measure>
    <time_frame>6 months post-operative</time_frame>
    <description>Percentage of subjects reporting that they never wear glasses at the 6 month post-operative visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IOL Rotation</measure>
    <time_frame>6 months post-operative</time_frame>
    <description>Evaluation of percentage of patients that experienced rotation of the intraocular lens (IOL) less than or equal to 5 degrees from initial implantation, and less than or equal to 10 degrees from initial implantation.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>AcrySof Toric IOL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AcrySof Toric Intraocular Lens (IOL)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AcrySof Toric IOL</intervention_name>
    <description>Implantation with the AcrySof Toric IOL for cataract replacement and multiple follow-up assessments</description>
    <arm_group_label>AcrySof Toric IOL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Are a candidate for bilateral implantation

          -  In good general and ocular health, 21 years of age or older, of either gender or any
             race, diagnosed with age-related cataracts in both eyes

          -  In need of spherical correction between 10.0 Diopter (D) and 30.0 D

          -  Preoperative regular corneal astigmatism, ≥ 1.0 D and ≤ 2.5 D , as measured by
             keratometry

          -  Willing and able to complete all required postoperative visits

          -  Able to comprehend and sign a statement of informed consent

          -  Pupil dilation ≥ 6.0 mm

          -  Expected to achieve a postoperative logMAR +0.3 or better visual acuity (as assessed
             by one or more of the following: fundus examination, pinhole visual acuity, and/or PAM
             evaluation);

        Exclusion Criteria:

        Exclusion Criteria Before Surgery - Ocular

          -  Previous cataract patient without potential of bilateral implantation

          -  Females of child bearing potential

          -  Irregular corneal astigmatism

          -  Keratopathy/Keratectasia - any corneal abnormality including but not limited to the
             following: keratoconus, keratoglobus, keratolysis, keratomalacia, keratomycosis, and
             cornea plana

          -  Any inflammation or edema (swelling) of the cornea, including but not limited to the
             following: keratitis, keratoconjunctivitis, and keratouveitis

          -  Previous corneal reshaping, including but not limited to the following:
             keratomileusis, radial keratotomy (RK), photorefractive keratectomy (PRK), Laser in
             Situ Keratomileusis (LASIK), Thermal Keratoplasty (TK), and Penetrating Keratoplasty
             (PK)

          -  Clinically significant corneal dystrophy (including Fuch's dystrophy)

          -  Previous corneal transplant

          -  Amblyopia

          -  Glaucoma (medically uncontrolled)

          -  Clinically significant RPE/Macular changes

          -  Proliferative diabetic retinopathy

          -  History of macular edema

          -  Previous history of retinal detachment

          -  History of uveitis/iritis

          -  Extremely shallow anterior chamber, not due to swollen cataract

          -  Iris neovascularization

          -  Microphthalmos

          -  Absent eye or eye with no light perception (NLP) as fellow eye

          -  Rubella, congenital, traumatic, or complicated cataract

          -  Optic atrophy

        Exclusion Criteria During Surgery

          -  Other procedures at this surgery

          -  Limbal relaxing incisions (LRIs) or any other procedure to reduce the amount of
             preoperative astigmatism on the study eye(s), whether implanted with SA60TT or SA60AT,
             for the duration of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alcon Call Center</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2008</study_first_submitted>
  <study_first_submitted_qc>September 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2008</study_first_posted>
  <results_first_submitted>September 22, 2009</results_first_submitted>
  <results_first_submitted_qc>March 25, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 7, 2010</results_first_posted>
  <last_update_submitted>January 12, 2012</last_update_submitted>
  <last_update_submitted_qc>January 12, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2012</last_update_posted>
  <responsible_party>
    <name_title>Ms Myrna Bergen, Phase IV Clinical Research Manager</name_title>
    <organization>Alcon Canada Inc.</organization>
  </responsible_party>
  <keyword>Cataract AcrySof Toric IOL</keyword>
  <keyword>Bilateral cataract</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects &gt;21 years of age, either sex and any race. Diagnosis of cataracts in one or both eyes.</recruitment_details>
      <pre_assignment_details>Subject’s eligibility was determined at the preoperative visit. All subjects met inclusion/exclusion criteria.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>AcrySof Toric IOL</title>
          <description>Implantation of the AcrySof Toric Intraocular lens (IOL)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="120"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="117"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Unilateral implantation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>AcrySof Toric IOL</title>
          <description>Implantation of the AcrySof Toric Intraocular lens (IOL)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="120"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity (VA)</title>
        <description>Pre-operative and 1 month, 3 month, and 6 month post-operative visual acuity (VA) measured in logMAR. LogMAR is the “logarithm of the minimum angle of resolution”. It is a unit of measure for visual acuity (VA).</description>
        <time_frame>Pre-operative, 1 month, 3 month, and 6 month post-operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>AcrySof Toric IOL</title>
            <description>Implantation of the AcrySof Toric Intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity (VA)</title>
          <description>Pre-operative and 1 month, 3 month, and 6 month post-operative visual acuity (VA) measured in logMAR. LogMAR is the “logarithm of the minimum angle of resolution”. It is a unit of measure for visual acuity (VA).</description>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="117"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Operative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Day Post-operative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months Post-operative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months Post-operative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Spectacle Independence</title>
        <description>Percentage of subjects reporting that they never wear glasses at the 6 month post-operative visit</description>
        <time_frame>6 months post-operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>AcrySof Toric IOL</title>
            <description>Implantation of the AcrySof Toric Intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>Spectacle Independence</title>
          <description>Percentage of subjects reporting that they never wear glasses at the 6 month post-operative visit</description>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="117"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>IOL Rotation</title>
        <description>Evaluation of percentage of patients that experienced rotation of the intraocular lens (IOL) less than or equal to 5 degrees from initial implantation, and less than or equal to 10 degrees from initial implantation.</description>
        <time_frame>6 months post-operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>AcrySof Toric IOL</title>
            <description>Implantation of the AcrySof Toric Intraocular lens (IOL)</description>
          </group>
        </group_list>
        <measure>
          <title>IOL Rotation</title>
          <description>Evaluation of percentage of patients that experienced rotation of the intraocular lens (IOL) less than or equal to 5 degrees from initial implantation, and less than or equal to 10 degrees from initial implantation.</description>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="117"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Less than or equal to 5 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Less than or equal to 10 degrees</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>AcrySof Toric IOL</title>
          <description>Implantation of the AcrySof Toric Intraocular lens (IOL)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Lens Repositioning</sub_title>
                <description>Repositioning of the intraocular lens during outpatient procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="120"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>No paper that incorporates Sponsor Condfidential information will be submitted for publication without Sponsor’s prior written agreement.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alcon Clinical</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>888.451.3937; 817.568.6725</phone>
      <email>medinfo@alconlabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

